RT Journal Article
SR Electronic
T1 Supremacy of attention based convolution neural network in classification of oral cancer using histopathological images
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.11.13.22282265
DO 10.1101/2022.11.13.22282265
A1 Singha Deo, Bhaswati
A1 Pal, Mayukha
A1 Panigrahi, Prasanta K.
A1 Pradhan, Asima
YR 2022
UL http://medrxiv.org/content/early/2022/11/14/2022.11.13.22282265.abstract
AB Introduction Oral cancer has grown to be one of the most prevalent malignant tumours and one of the deadliest diseases in emerging and low-to-middle income nations. The mortality rate can be significantly reduced if oral cancer is detected early and treated effectively.Objectives This study proposes an effective histopathological image classification model for oral cancer diagnosis using Vision Transformer deep learning based on multi-head attention mechanism.Methods The oral histopathological image dataset used in the study consists of 4946 images, which were categorized into 2435 images of healthy oral mucosa and 2511 images of oral squamous cell carcinoma (OSCC). In our proposed approach, along with Vision Transformer model eight pre-trained deep learning models known as Xception, Resnet50, InceptionV3, InceptionResnetV2, Densenet121, Densenet169, Densenet201 and EfficientNetB7 have been used for the comparative analysis. 90% of the images are used for training the models while the rest 10% of the images are used for testing purposes.Results Vision Transformer model achieved the highest classification accuracy of 97.78% in comparison to other considered deep learning models. Specificity, sensitivity and ROC AUC score are recorded as 96.88%, 98.74% and 97.74% respectively.Conclusion We found that our proposed Vision Transformer model outperforms compared to other pre-trained deep learning models, demonstrating a stronger transfer ability of the learning in histopathological image classification from the analysis of the obtained results. This method considerably lowers the cost of diagnostic testing while increasing the diagnostic effectiveness, and accuracy for oral cancer detection in patients of diverse origin.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:https://www.kaggle.com/ashenafifasilkebede/dataset?select=valI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yeshttps://www.kaggle.com/ashenafifasilkebede/dataset?select=val https://www.kaggle.com/ashenafifasilkebede/dataset?select=val